focus -WSS

focus

author：leisure time 2025-09-06 04:14:13 - browse：5

There’s a specter haunting Wall Street.

It started in biotech, where companies making drugs for the obesity-related liver disease NASH saw their valuations crash on the assumption that GLP-1 weight loss treatments would cut them out of the market. Then the Ozempic panic came for dialysis firms, whose stocks fell about 20% in a single day on the news that Novo Nordisk’s medicine had delayed the progression of kidney disease in a study enrolling people with type 2 diabetes.

Now analysts from every sector are cranking out research notes on the disparate, dramatic, and often debatable implications of GLP-1 drugs’ growing popularity, said Jared Holz, a health care specialist at Mizuho Securities. Buy Bumble, sell McDonald’s. Short Pepsi, go long Louis Vuitton. Put your money in sectors that cater to a svelte and sated brand of consumer, and get out of the ones that rely on excess and compulsion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Wikipedia

WSS

Group opposing PBM reform sets lobbying record

Doctors find melanoma drugs effective against rare brain cancer

'Insanity': 4th of July mass shootings across US kill 13, injure more than 80

Listen: Wegovy in the brain & pivotal Alzheimer's data

In early work, researchers turn to CRISPR to treat Alzheimer's

STAT Virtual Event: The State of Biosimilars: What to Watch

explore

focus

explore

In age of alternative facts, a scholarly course on calling out crap

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

BioMarin wins approval for gene therapy to treat hemophilia A

Pope Francis asks Church to identify 21st

In Memoriam: Notable people who died in 2023

Doctors find melanoma drugs effective against rare brain cancer

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

In early work, researchers turn to CRISPR to treat Alzheimer's

Peter Hotez and the public health issue of online harassment

Sanofi seeks simpler, safer CRISPR sickle cell cure

leisure time

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Doctors find melanoma drugs effective against rare brain cancer

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

Custom gene therapy hints at new path for rare disease treatments

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Pope Francis asks Church to identify 21st

explore

focus

Wikipedia

focus